Bedford Labs Recalls Drug
Bedford Recall
Bedford Laboratories (Bedford, OH, www.bedfordlabs.com), a division of Ben Venue Laboratories, Inc., (Bedford, OH, www.benvenue.com) voluntarily recalled one lot of famotidine injection, 20 mg/2-mL (NDC 55390-029-10), lot no. 609336, with an expiration date of April 2006, because of a lack of sterility assurance.
The prescription product was distributed in August 2004 throughout the United States to wholesalers and distributors, who further distributed the product to hospitals. According to an FDA posting, customers that have any vials of this lot of famotidine injection should discontinue distribution and use of the drug immediately and contact Bedford Laboratories' customer service department (tel. 800.562.4797) for a returned goods authorization.
Bedford Laboratories is working with FDA on this recall, and to date no serious health or safety reports have been attributed to the defective lot.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
